Device Trial Radar · NCT04911387
iCare® Home vs Goldmann Applanation Tonometry
Last checked: Nov 20, 2026Latest source record: Jun 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
61
Actual
Start
Apr 1, 2020
Primary completion
Oct 31, 2020
Study completion Oct 31, 2020
Sponsor
- Lead sponsor
- St. Erik Eye HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 3, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Self-tonometry with iCare Home is regularly performed at Sankt Erik's Eye Hospital since a few years back. The purpose of this study was to show that the eye pressure measurements made with iCare® Home by patients / relatives do not vary more than those made with the standard method, Goldman applanation tonometry (GAT), by different healthcare professionals. This will hopefully confirm the usefulness of self-tonometry.
Conditions
- Glaucoma
- Open Angle Glaucoma
- Ocular Hypertension
- Pseudo Exfoliation Syndrome
Interventions
Intraocular pressure measurmentsDevice
Intraocular pressure measurements with iCare Home by participants (patients, volunteers) and healthcare staff as well as intraocular pressure measurements with GAT by participants different healthcare staff.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Correlation between iCare® Home inter-user measurementsTime frame: 12 months
- Correlation between GAT measurements made by different healthcare personnelTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
St Erik Eye Hospital
Stockholm, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.